Hamilton Thorne Ltd.
HTL
Rang in Aktien
#16938
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Aktienkurs
$1.64
Zuletzt synchronisiert: 2024-12-02
Marktkapitalisierung
$253.46M
Veränderung (1 Tag)
2.87%
Veränderung (1 Jahr)
3.40%
Land
US
Handel Hamilton Thorne Ltd. (HTL)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Hamilton Thorne Ltd. (HTL)
Anzahl der ausstehenden Aktien zum September 2024: 153.95M
Laut den neuesten Finanzberichten und dem Aktienkurs von Hamilton Thorne Ltd. beträgt die aktuelle Anzahl der ausstehenden Aktien 153.95M. Am Ende von December 2022 hatte das Unternehmen 143.87M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Hamilton Thorne Ltd. (HTL) von 2008 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 153.95M | 4.43% |
| 2023 | 147.42M | 2.47% |
| 2022 | 143.87M | 2.24% |
| 2021 | 140.72M | 4.75% |
| 2020 | 134.33M | 9.29% |
| 2019 | 122.92M | -2.51% |
| 2018 | 126.08M | 28.17% |
| 2017 | 98.37M | 35.53% |
| 2016 | 72.58M | 14.95% |
| 2015 | 63.14M | 18.83% |
| 2014 | 53.13M | 2.05% |
| 2013 | 52.06M | 4.79% |
| 2012 | 49.69M | 59.91% |
| 2011 | 31.07M | 27.26% |
| 2010 | 24.42M | 39.48% |
| 2009 | 17.50M | 1,103.14% |
| 2008 | 1.45M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 354.50M | 130.27% |
US
|
|
| 461.20M | 199.58% |
FR
|
|
| - | - |
JP
|
|
| 274.79M | 78.49% |
US
|
|
| - | - |
CH
|
